- Home
- AMT vs SNY Comparison
AMT vs SNY Comparison
Compare AMT & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMT | SNY |
|---|---|---|
| Founded | 1995 | 1994 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 84.8B | 119.4B |
| IPO Year | 1998 | N/A |
Fundamental Metrics
Financial Performance| Metric | AMT | SNY |
|---|---|---|
| Price | $178.27 | $46.24 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 6 |
| Target Price | ★ $224.53 | $61.50 |
| AVG Volume (30 Days) | ★ 2.9M | 2.8M |
| Earning Date | 02-24-2026 | 01-29-2026 |
| Dividend Yield | ★ 3.83% | 3.50% |
| EPS Growth | ★ 164.45 | 105.93 |
| EPS | 6.27 | ★ 8.67 |
| Revenue | $10,454,700,000.00 | ★ $53,890,648,839.00 |
| Revenue This Year | $5.61 | $1.73 |
| Revenue Next Year | $3.40 | $6.49 |
| P/E Ratio | $28.36 | ★ $5.27 |
| Revenue Growth | ★ 4.17 | N/A |
| 52 Week Low | $166.88 | $44.62 |
| 52 Week High | $234.33 | $60.12 |
Technical Indicators
Market Signals| Indicator | AMT | SNY |
|---|---|---|
| Relative Strength Index (RSI) | 52.67 | 38.07 |
| Support Level | $166.88 | $45.25 |
| Resistance Level | $184.17 | $48.17 |
| Average True Range (ATR) | 4.33 | 0.71 |
| MACD | 0.97 | -0.19 |
| Stochastic Oscillator | 65.88 | 24.21 |
Price Performance
Historical ComparisonAbout AMT American Tower Corporation (REIT)
American Tower owns and operates about 150,000 wireless towers throughout the US, Asia, Latin America, Europe, and Africa. It also owns and/or operates 30 data centers in 11 US markets after acquiring CoreSite. On its towers, the company has a very concentrated customer base, with most revenue in each market generated by the top few mobile carriers. The company operates more than 40,000 towers in the US, which accounted for about half of total revenue in 2024. Outside the US, American Tower operates about 47,000 towers in Latin America (dominated by Brazil), 32,000 towers in Europe, and 27,000 towers in Africa. American Tower operates as a REIT.
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.